Alumis ALMS
NASDAQ ALMS
$7.21 -0.18 (-2.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Alumis (ALMS) Preferred Stock Liabilities (2023 - 2024)

Updated

Alumis' Preferred Stock Liabilities came in at $639.24 million for Q2 2024, up 86.3% from $343.15 million a year earlier and up 29.0% from the prior quarter.

Analysis

Alumis (ALMS) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

At the end of FY2023, Alumis' Preferred Stock Liabilities was $375.37 million.

  • Business Quant data shows ALMS's Preferred Stock Liabilities at $495.58 million (Q1 2024), $375.37 million (Q4 2023) and $343.15 million (Q3 2023) in the three quarters before Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Alumis 919.65 Mn -755.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 639.24 Mn
Mar 31, 2024 495.58 Mn
Dec 31, 2023 375.37 Mn
Sep 30, 2023 343.15 Mn
Jun 30, 2023 343.15 Mn
API Access

Alumis Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ALMS&period=max&api_key=YOUR_API_KEY